These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29266692)

  • 1. Response-adaptive designs for binary responses: How to offer patient benefit while being robust to time trends?
    Villar SS; Bowden J; Wason J
    Pharm Stat; 2018 Mar; 17(2):182-197. PubMed ID: 29266692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A response-adaptive randomization procedure for multi-armed clinical trials with normally distributed outcomes.
    Williamson SF; Villar SS
    Biometrics; 2020 Mar; 76(1):197-209. PubMed ID: 31322732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian response adaptive randomization using longitudinal outcomes.
    Hatayama T; Morita S; Sakamaki K
    Pharm Stat; 2015; 14(5):369-76. PubMed ID: 26099995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian adaptive bandit-based designs using the Gittins index for multi-armed trials with normally distributed endpoints.
    Smith AL; Villar SS
    J Appl Stat; 2018; 45(6):1052-1076. PubMed ID: 29551849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-trend impact on treatment estimation in two-arm clinical trials with a binary outcome and Bayesian response adaptive randomization.
    Jiang Y; Zhao W; Durkalski-Mauldin V
    J Biopharm Stat; 2020; 30(1):69-88. PubMed ID: 31017843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of multi-arm multi-stage design and adaptive randomization in platform clinical trials.
    Lin J; Bunn V
    Contemp Clin Trials; 2017 Mar; 54():48-59. PubMed ID: 28089763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of statistical features of a Bayesian two-armed responsive adaptive randomization trial with post hoc analysis of time trend drift.
    Shergina E; Richter KP; Zhang C; Mussulman L; Nazir N; Gajewski BJ
    J Biopharm Stat; 2024 Jun; ():1-15. PubMed ID: 38847351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simulation study for evaluating the performance of response-adaptive randomization.
    Du Y; Wang X; Jack Lee J
    Contemp Clin Trials; 2015 Jan; 40():15-25. PubMed ID: 25460340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A group sequential, response-adaptive design for randomized clinical trials.
    Karrison TG; Huo D; Chappell R
    Control Clin Trials; 2003 Oct; 24(5):506-22. PubMed ID: 14500050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Block response-adaptive randomization in clinical trials with binary endpoints.
    Magirr D
    Pharm Stat; 2011; 10(4):341-6. PubMed ID: 22328326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urn models for response-adaptive randomized designs: a simulation study based on a non-adaptive randomized trial.
    Ghiglietti A; Scarale MG; Miceli R; Ieva F; Mariani L; Gavazzi C; Paganoni AM; Edefonti V
    J Biopharm Stat; 2018; 28(6):1203-1215. PubMed ID: 29565749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A surrogate-primary replacement algorithm for response-adaptive randomization in stroke clinical trials.
    Nowacki AS; Zhao W; Palesch YY
    Stat Methods Med Res; 2017 Jun; 26(3):1078-1092. PubMed ID: 25586325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive biased-coin designs for skewing the allocation proportion in clinical trials with normal responses.
    Atkinson AC; Biswas A
    Stat Med; 2005 Aug; 24(16):2477-92. PubMed ID: 16007571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of response adaptive randomization features in multiarm clinical trials with control.
    Viele K; Saville BR; McGlothlin A; Broglio K
    Pharm Stat; 2020 Sep; 19(5):602-612. PubMed ID: 32198968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronological bias in randomized clinical trials arising from different types of unobserved time trends.
    Tamm M; Hilgers RD
    Methods Inf Med; 2014; 53(6):501-10. PubMed ID: 25396221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient and ethical response-adaptive randomization designs for multi-arm clinical trials with Weibull time-to-event outcomes.
    Sverdlov O; Ryeznik Y; Wong WK
    J Biopharm Stat; 2014; 24(4):732-54. PubMed ID: 24697678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling the family-wise error rate in multi-arm, multi-stage trials.
    Crouch LA; Dodd LE; Proschan MA
    Clin Trials; 2017 Jun; 14(3):237-245. PubMed ID: 28545335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical inference for response adaptive randomization procedures with adjusted optimal allocation proportions.
    Zhu H
    J Biopharm Stat; 2017; 27(5):732-740. PubMed ID: 27937121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exact group-sequential designs for clinical trials with randomized play-the-winner allocation.
    Stallard N; Rosenberger WF
    Stat Med; 2002 Feb; 21(4):467-80. PubMed ID: 11836730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian dose selection design for a binary outcome using restricted response adaptive randomization.
    Meinzer C; Martin R; Suarez JI
    Trials; 2017 Sep; 18(1):420. PubMed ID: 28886745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.